(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

THERANOVA

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

THERANOVA

ST13

US500000087976728

Class

35, 42

Filing

87976728

Registration

5420042

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

35

Latest update

10/23/2024

Trademark type

Word

Nice classes

35, 42

Filing date

06/23/2016

Registration date

03/06/2018

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

10/23/2024

Last transaction

10/23/2024

Responsible office

United States Patent and Trademark Office

Status code

702

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

12/31/2005

First use in commerce

12/31/2005

Drawing code

4

Owner type

16

Owner location

San Francisco, CA, US

Examiner

MULLEN, MARK

Current location

Historical data usage

Holders and representatives

Holders

Theranova LLC

Representatives

Donald A. Thompson THOMPSON & CO.

Technical classification

Nice Classes

Class 35Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 35

Business consulting services in the field of medical devices; Business consulting and management in the field of clinical trials concerning medical devicesproviding information management services; Business consulting services in the field of regulatory approvals concerning medical devices; Providing consulting services in the field of regulatory submission management to medical companies to assist them with applications for medical device approval; Business consulting services in the field of regulatory submissions concerning medical devices; Business consulting and management in the field of clinical trialsclinical data and regulatory submission management on behalf of medicalbiopharmaceutical and biotechnology companies to assist them with clinical researchclinical trials and applications for medical device approval; Business consulting and management in the field of clinical trials concerning medical devicesproviding information management services; Business consulting services in the field of quality system information management concerning medical devices; Regulatory submission managementassisting others in preparing and filing applications for medical devices with governmental regulatory bodies; in each caseexcept in connection with dialysis

Class 42

Consulting services in the field of medical device product development; Consulting servicesproduct testingproduct safety testing and product quality testing consultation in the field of experimental tests concerning medical devices; Consulting services regarding the conducting of clinical trials for others relating to medical devices in the field of physical paincardiovascular diseasediabetesosteoporosisdementiaincontinenceoveractive bladdervascular accessbody fluid drainageenteral feeding and monitoring; New product designengineeringresearchdevelopment services for others in the field of medical devices; in each caseexcept in the field of dialysis

Publications

History of USPTO decisions and trademark events.

35 publications found

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

10/23/2024

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

10/23/2024

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

10/23/2024

E815

TEAS SECTION 8 & 15 RECEIVED

04/29/2024

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

03/06/2023

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

11/22/2019

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

11/22/2019

R.PR

REGISTERED-PRINCIPAL REGISTER

03/06/2018

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

01/31/2018

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

01/30/2018

SUPC

STATEMENT OF USE PROCESSING COMPLETE

01/30/2018

DPCC

DIVISIONAL PROCESSING COMPLETE

01/30/2018

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

01/29/2018

IUAF

USE AMENDMENT FILED

01/17/2018

DRRR

DIVISIONAL REQUEST RECEIVED

01/17/2018

ERTD

TEAS REQUEST TO DIVIDE RECEIVED

01/17/2018

EISU

TEAS STATEMENT OF USE RECEIVED

01/17/2018

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

08/01/2017

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

06/06/2017

PUBO

PUBLISHED FOR OPPOSITION

06/06/2017

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

05/17/2017

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

04/25/2017

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

03/29/2017

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

03/28/2017

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

03/28/2017

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

02/27/2017

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

02/27/2017

DOCK

ASSIGNED TO EXAMINER

01/09/2017

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

10/06/2016

GNRT

NON-FINAL ACTION E-MAILED

10/06/2016

CNRT

NON-FINAL ACTION WRITTEN

10/06/2016

DOCK

ASSIGNED TO EXAMINER

09/29/2016

MPMK

NOTICE OF PSEUDO MARK E-MAILED

06/30/2016

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

06/29/2016

NWAP

NEW APPLICATION ENTERED

06/27/2016

Continuous trademark protection

Get notified about every new filing that threatens THERANOVA or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.